Showing results (61-70 of 140) with videos related to
Sort By:
Pageof 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2024
Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA)Jii Bum Lee, Su-Jin Choi, Hyo Sup Shim, et al.Cancer Discovery|May 8, 2024
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical ActivitiesJing Zhang, Sun Min Lim, Mi Ra Yu, et al.Clinical Lung Cancer|August 24, 2022
A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)Kyung Hwan Kim, Shinkyo Yoon, Hee Kyung Ahn, et al.Digestive Diseases and Sciences|February 4, 2012
Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammationKi Tae Yoon, Sun Min Lim, Jun Yong Park, et al.Cancer Chemotherapy and Pharmacology|September 10, 2013
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patientsHye Ryun Kim, Hyung Soon Park, Woo Sun Kwon, et al.Cancer Research and Treatment|April 2, 2026
Synergistic Antitumor Activity of Combination Therapy with a MET TKI Vabametkib and a Third-Generation EGFR TKI Lazertinib in MET-Amplified EGFR-Mutant NSCLCDong Kwon Kim, Jin Woo Park, Hyeon Bin Cho, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
A Phase 2 Study of Stereotactic Ablative Radiotherapy Plus Atezolizumab Plus Tiragolumab in Treatment-naïve Patients with Advanced Non-small Cell Lung CancerJii Bum Lee, Dong Kwon Kim, Sang Hoon Lee, et al.Gut and Liver|May 28, 2013
Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis BDo Young Kim, Hye Young Chang, Sun Min Lim, et al.Anticancer Research|June 11, 2013
Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cellsSun Min Lim, Jee Won Hwang, Joong Bae Ahn, et al.Journal of Cancer Research and Clinical Oncology|February 22, 2021
Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patientsSun Min Lim, Min Hee Hong, Sang-Jun Ha, et al.Pageof 14